265 related articles for article (PubMed ID: 6384377)
1. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
Gurwith M; Truog K; Hinthorn D; Liu C
Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
[TBL] [Abstract][Full Text] [Related]
3. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Bow EJ; Rayner E; Scott BA; Louie TJ
Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
[TBL] [Abstract][Full Text] [Related]
4. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
Braine HG; Stuart RK; Saral R; Lietman PS
Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
[TBL] [Abstract][Full Text] [Related]
5. Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.
Young LS; Hindler J
Rev Infect Dis; 1987; 9 Suppl 2():S177-83. PubMed ID: 3554456
[TBL] [Abstract][Full Text] [Related]
6. The importance of surveillance stool cultures during periods of severe neutropenia.
Wells CL; Ferrieri P; Weisdorf DJ; Rhame FS
Infect Control; 1987 Aug; 8(8):317-9. PubMed ID: 3308740
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
Malarme M; Meunier-Carpentier F; Klastersky J
Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
[No Abstract] [Full Text] [Related]
8. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
Riben PD; Louie TJ; Lank BA; Kornachuk E; Gurwith MJ; Harding GK; Ronald AR
Cancer; 1983 May; 51(9):1587-92. PubMed ID: 6339029
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.
de Jongh CA; Wade JC; Finley RS; Joshi JH; Aisner J; Wiernik PH; Schimpff SC
J Clin Oncol; 1983 May; 1(5):302-7. PubMed ID: 6321684
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
Kim KS; Anthony BF
Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
[TBL] [Abstract][Full Text] [Related]
11. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
Fox BC; Sollinger HW; Belzer FO; Maki DG
Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
[TBL] [Abstract][Full Text] [Related]
13. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.
Cohen J; Donnelly JP; Worsley AM; Catovsky D; Goldman JM; Galton DA
Lancet; 1983 Dec 24-31; 2(8365-66):1452-4. PubMed ID: 6140545
[TBL] [Abstract][Full Text] [Related]
14. Use of trimethoprim-sulfamethoxazole for treatment of infections in patients with cancer.
Bodey GP; Grose WE; Keating MJ
Rev Infect Dis; 1982; 4(2):579-85. PubMed ID: 6981174
[TBL] [Abstract][Full Text] [Related]
15. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients.
Tolkoff-Rubin NE; Cosimi AB; Russell PS; Rubin RH
Rev Infect Dis; 1982; 4(2):614-8. PubMed ID: 7051249
[TBL] [Abstract][Full Text] [Related]
16. Prevention of infection in the neutropenic patient.
Verhoef J; Rozenberg-Arska M; Dekker A
Rev Infect Dis; 1989; 11 Suppl 7():S1545-50. PubMed ID: 2513630
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis with trimethoprim-sulfamethoxazole in abdominal, pelvic, and prostatic surgery.
Apuzzio JJ; Ganesh VV; Dispensiere BR; Miller AM; Louria DB
Rev Infect Dis; 1987; 9 Suppl 2():S211-7. PubMed ID: 3554459
[TBL] [Abstract][Full Text] [Related]
18. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.
Markowitz N; Quinn EL; Saravolatz LD
Ann Intern Med; 1992 Sep; 117(5):390-8. PubMed ID: 1503330
[TBL] [Abstract][Full Text] [Related]
20. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
Hughes DT; Russell NJ
Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
